Suppr超能文献

[在临床级培养方案中,胸腺球蛋白可有效扩增细胞因子诱导的杀伤细胞]

[Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].

作者信息

Chen Wei, Lin Di, Jiang Zhiming, Yang Zien, Song Shuang, Zhou Jian, Zhou Li, Sun Yinghui, Yu Huiying, Ma Dongchu

机构信息

Department of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenyang 110840, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jul;30(7):681-5, 690.

Abstract

OBJECTIVE

To study the effect of thymoglobulin (TG) on proliferation, immune cell phenotype and cytotoxicity of cytokine-induced killer (CIK) cells in a clinical-grade culture protocol.

METHODS

Peripheral blood mononuclear cells (PBMCs) isolated from 11 healthy donors were primed with IFN-γ on day 0 and treated with either TG or CD3 mAb on day 1. Thereafter, the cells were fed with IL-2 every 3 days until day 21. Aliquots of cells were harvested weekly. The cell number and viability were measured using trypan blue exclusion. The expressions of CD3, CD4, CD8, CD16/CD56, NK activating/inhibitory receptor, and the CD25⁺ Foxp3⁺ regulatory T cells (Tregs) were analyzed with flow cytometry. The cytotoxicity of CIK cells against K562 cells were determined by lactate dehydrogenase (LDH) release assay on day 16 and day 21.

RESULTS

Both TG and CD3 mAb stimulated the growth of CIK cells. However, the effect of CD3 mAb was weaker than that of TG. Flow cytometric analysis showed that the percentages of CD3⁺ CD16⁺ CD56⁺ cells and CD3⁻ CD16⁺ CD56⁺ cells and the expression of NK activating/inhibitory receptor recovered and increased continuously until the end of culture (day 21) following a transient decrease at day 7. Noticeably, on day 7, 14 and 21, the percentages of CD3⁺ CD 16⁺ CD56⁺ cells and CD3⁻ CD16⁺ CD56⁺ cells as well as the expression of NK activating/inhibitory receptor were higher in TG-induced CIK cells than those in CD3 mAb-induced CIK cells (P<0.05); Moreover, LDH release assay revealed that the cytotoxicity of CIK cells against K562 cells in TG-induced CIK cells was significantly higher than that of CD3 mAb-induced CIK cells (P<0.05). In both CD3 mAb-induced CIK cell culture system and TG-induced CIK cell culture system, Treg increased transiently at day 7; moreover, the percentage of Treg in TG-induced CIK cells was significantly higher than that of CD3 mAb-induced CIK cells (P<0.05). In addition, both CD3 mAb and TG reduced the percentage of CD3⁺ CD4⁺ cells continuously, meanwhile increased the percentage of CD3⁺ CD8⁺ cells. There was no significant difference in the changes of CD3⁺ CD4⁺ cells and CD3⁺ CD8⁺ cells between the two CIK cell culture systems.

CONCLUSION

Compared with CD3 mAb, TG more selectively expanded CD3⁺ CD16⁺ CD56⁺ cells and CD3⁻ CD16⁺ CD56⁺ cells (CIK effector cells) and promoted the differentiation and maturation of these CIK effector cells with more powerful cytotoxic activity. Therefore, it is feasible for TG to substitute CD3 mAb to prepare the clinical grade products of CIK cells. Both CD3 mAb and TG increased negative regulatory cells, Tregs, transiently in CIK culture system and depleting or reducing Tregs might be helpful for increasing the production efficacy of the main effector cells in CIK cells.

摘要

目的

在临床级培养方案中研究胸腺球蛋白(TG)对细胞因子诱导的杀伤细胞(CIK)增殖、免疫细胞表型及细胞毒性的影响。

方法

从11名健康供者分离外周血单个核细胞(PBMC),于第0天用γ干扰素预处理,第1天用TG或CD3单克隆抗体处理。此后,每3天用白细胞介素-2培养细胞至第21天。每周收集细胞 aliquots。用台盼蓝拒染法检测细胞数量和活力。用流式细胞术分析CD3、CD4、CD8、CD16/CD56、NK激活/抑制性受体以及CD25⁺Foxp3⁺调节性T细胞(Tregs)的表达。在第16天和第21天通过乳酸脱氢酶(LDH)释放试验测定CIK细胞对K562细胞的细胞毒性。

结果

TG和CD3单克隆抗体均刺激CIK细胞生长。然而,CD3单克隆抗体的作用弱于TG。流式细胞术分析显示,CD3⁺CD16⁺CD56⁺细胞和CD3⁻CD16⁺CD56⁺细胞的百分比以及NK激活/抑制性受体的表达在第7天短暂下降后持续恢复并增加直至培养结束(第21天)。值得注意的是,在第7天、14天和21天,TG诱导的CIK细胞中CD3⁺CD16⁺CD56⁺细胞和CD3⁻CD16⁺CD56⁺细胞的百分比以及NK激活/抑制性受体的表达高于CD3单克隆抗体诱导的CIK细胞(P<0.05);此外,LDH释放试验显示,TG诱导的CIK细胞对K562细胞的细胞毒性显著高于CD3单克隆抗体诱导的CIK细胞(P<0.05)。在CD3单克隆抗体诱导的CIK细胞培养系统和TG诱导的CIK细胞培养系统中,Tregs在第7天均短暂增加;此外,TG诱导的CIK细胞中Tregs的百分比显著高于CD3单克隆抗体诱导的CIK细胞(P<0.05)。另外,CD3单克隆抗体和TG均持续降低CD3⁺CD4⁺细胞的百分比,同时增加CD3⁺CD8⁺细胞的百分比。两种CIK细胞培养系统中CD3⁺CD4⁺细胞和CD3⁺CD8⁺细胞的变化无显著差异。

结论

与CD3单克隆抗体相比,TG更具选择性地扩增CD3⁺CD16⁺CD56⁺细胞和CD3⁻CD16⁺CD56⁺细胞(CIK效应细胞),并促进这些具有更强细胞毒性活性的CIK效应细胞的分化和成熟。因此,TG替代CD3单克隆抗体制备CIK细胞临床级产品是可行的。CD3单克隆抗体和TG在CIK培养系统中均短暂增加负调节细胞Tregs,清除或减少Tregs可能有助于提高CIK细胞中主要效应细胞得率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验